Company news
BioRestorative Therapies, Inc. news in 2025
BioRestorative Therapies, Inc.'s news releases, calls and decks from 2025, newest first.
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease
November 17, 2025
BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update
November 12, 2025
BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025
November 5, 2025
BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market
October 27, 2025
BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio
October 22, 2025
BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit
October 15, 2025
BioRestorative CEO Lance Alstodt Interviewed on “The Big Biz Show”
October 7, 2025
BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market
October 6, 2025
BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
August 12, 2025
BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025
August 5, 2025
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
June 18, 2025
BioRestorative Announces Share Repurchase Program
June 17, 2025
BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease
June 13, 2025
BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team
June 10, 2025
BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025
June 9, 2025
BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
May 13, 2025
BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
May 8, 2025
BioRestorative to Present a BRTX-100 Clinical Update at ISCT 2025
May 7, 2025
BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease
April 15, 2025
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities
April 15, 2025
BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States
April 10, 2025
BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
March 27, 2025
BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025
March 20, 2025
BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
February 27, 2025
BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update
February 26, 2025
BioRestorative to Provide a Positive FDA Update on Clinical Pipeline
February 25, 2025
BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program
February 20, 2025
Calls in 2025
- BioRestorative Therapies (NASDAQ:BRTX) Q3 2025 Earnings Call
Nov 12, 2025
Transcript - BioRestorative Therapies (NASDAQ:BRTX) Q2 2025 Earnings Call
Aug 12, 2025
Transcript - BioRestorative Therapies (NASDAQ:BRTX) Q1 2025 Earnings Call
May 14, 2025
Transcript - BioRestorative Therapies (NASDAQ:BRTX) Q4 2024 Earnings Call
Mar 27, 2025
Transcript
Decks in 2025
- Investor Presentation (September 2025)
Investor deck · 27 slides · September 2025
- Investor Presentation (August 2025)
Investor deck · 27 slides · Aug 14, 2025
- Q1 2025 Earnings Presentation
Earnings · 27 slides · May 14, 2025
- Investor Presentation (May 2025)
Investor deck · 27 slides · May 2025
- Investor Presentation (April 2025)
Investor deck · 27 slides · April 2025
- Investor Presentation (February 2025)
Investor deck · 20 slides · Feb 10, 2025